Targeting activated T cells: Successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis [1]

H. U. Scherer*, G. R. Burmester, G. Riemekasten

*Corresponding author for this work
26 Citations (Scopus)
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Issue number9
Pages (from-to)1245-1247
Number of pages3
Publication statusPublished - 09.2006

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this